Lingtao Jin Selected Research

lestaurtinib

1/2021	Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1.
10/2019	Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation.
1/2018	MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lingtao Jin Research Topics

Disease

22	Neoplasms (Cancer) 06/2022 - 04/2009
3	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2009
3	Inflammation (Inflammations) 01/2021 - 11/2017
3	Neoplasm Metastasis (Metastasis) 11/2013 - 04/2009
2	Breast Neoplasms (Breast Cancer) 07/2021 - 06/2011
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2020
2	Fibrosis (Cirrhosis) 01/2018 - 04/2009
2	Leukemia 08/2014 - 06/2011
1	Necrosis 06/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Triple Negative Breast Neoplasms 07/2021
1	Carcinogenesis 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Massive Hepatic Necrosis 01/2018
1	Sepsis (Septicemia) 01/2018
1	Pleomorphic Adenoma 01/2018
1	Melanoma (Melanoma, Malignant) 01/2017
1	Squamous Cell Carcinoma of Head and Neck 11/2013
1	Disease Progression 06/2011

Drug/Important Bio-Agent (IBA)

5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2018
4	PlatinumIBA 01/2021 - 01/2018
4	Small Interfering RNA (siRNA)IBA 01/2020 - 06/2011
4	naringeninIBA 01/2018 - 04/2009
3	LipidsIBA 09/2021 - 01/2020
3	lestaurtinibIBA 01/2021 - 01/2018
3	Phosphotransferases (Kinase)IBA 01/2020 - 06/2011
3	EnzymesIBA 01/2019 - 02/2015
2	SmokeIBA 05/2022 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 09/2021 - 10/2020
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 06/2011
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 08/2015
2	Glutamate DehydrogenaseIBA 01/2018 - 02/2015
2	CytokinesIBA 11/2017 - 04/2009
2	acetoacetic acid (acetoacetate)IBA 01/2017 - 08/2015
2	RSK inhibitor FMKIBA 11/2013 - 06/2011
2	Proteins (Proteins, Gene)FDA Link 11/2013 - 06/2011
1	Peptides (Polypeptides)IBA 06/2022
1	Detergents (Detergent)IBA 06/2022
1	sotorasibIBA 01/2022
1	DT2216IBA 01/2022
1	snake venom protein C activatorIBA 01/2022
1	Proteolysis Targeting ChimeraIBA 01/2022
1	CarcinogensIBA 01/2022
1	Annexin A5IBA 01/2022
1	Estrogen ReceptorsIBA 07/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Phosphatidic Acids (Phosphatidic Acid)IBA 01/2020
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2020
1	Diacylglycerol KinaseIBA 01/2020
1	Platinum Compounds (Compounds, Platinum)IBA 01/2020
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	inositol-1,3,4,5-tetrakisphosphateIBA 01/2019
1	Inositol (Myoinositol)IBA 01/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	NADPH Oxidase 4IBA 01/2019
1	flavanoneIBA 11/2017
1	KetonesIBA 01/2017
1	dehydroacetic acid (DHAS)IBA 01/2017
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2017
1	Dietary Fats (Dietary Fat)IBA 01/2017
1	Octamer Transcription Factor-1IBA 08/2015
1	Glutathione Peroxidase GPX1IBA 02/2015
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 02/2015
1	AntioxidantsIBA 02/2015
1	FumaratesIBA 02/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2015
1	Phosphogluconate Dehydrogenase (Dehydrogenase, Phosphogluconate)IBA 08/2014
1	Epidermal Growth Factor (EGF)IBA 08/2014
1	Lysine (L-Lysine)FDA Link 08/2014
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 11/2013
1	Microfilament Proteins (Actin Binding Proteins)IBA 11/2013
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 11/2013
1	Carrier Proteins (Binding Protein)IBA 11/2013
1	Biomarkers (Surrogate Marker)IBA 11/2013
1	MAP Kinase Kinase Kinase 5IBA 07/2013
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 07/2013
1	Cyclic AMP (AMP, Cyclic)IBA 07/2013
1	Tyrosine (L-Tyrosine)FDA Link 06/2011
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 06/2011
1	Messenger RNA (mRNA)IBA 06/2011
1	Adenosine (Adenocard)FDA LinkGeneric 06/2011
1	dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamineIBA 06/2011
1	FlavonoidsIBA 06/2011
1	Adenosine Triphosphate (ATP)IBA 06/2011
1	MicellesIBA 06/2011
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2011
1	Biological ProductsIBA 06/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2011

Therapy/Procedure

6	Therapeutics 06/2022 - 06/2011
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
1	Precision Medicine 01/2020
1	Ketogenic Diet 01/2017
1	Transplantation 06/2011